STOCK MARKET BSE NSE

COVID wave ebbing in Delhi, Mumbai, Kolkata?

An analysis of daily COVID cases and deaths in Delhi, Mumbai and Kolkata shows that the wave may have already peaked there.

Published: 18th January 2022 10:15 AM  |   Last Updated: 18th January 2022 10:15 AM   |  A+A-

Delhi Coronavirus

For representational purposes (Photo | EPS)

Express News Service

NEW DELHI: Though the ongoing third wave of Covid-19 continues to be building in the country, the curve in a few big cities may have started to bend.

An analysis of daily Covid cases and deaths in Delhi, Mumbai and Kolkata shows that the wave may have already peaked there. 

Mumbai logged 7,895 new cases on Sunday; its figures have been declining since January 7 when the city had a whopping 20,971 fresh cases.

The earlier one-day high for Mumbai was 11,163 cases, registered on April 4 last year during the second wave of the pandemic. 

In Delhi, where the daily Covid cases had crossed 30,000 on two days late last week, less than 28,000 were recorded on Sunday.

Though the number of tests, too, dropped a tad in the city, the good news is the fall in the test positivity rate (TPR) — under 28% now after crossing 30% earlier. 

Kolkata, which had shown an explosive TPR of over 70% for several days, is also reporting a marginal decline. Also, the daily case count in the city is now under 6,000 as against 10,000-plus earlier.

A senior member of the national Covid-19 task force told this newspaper that the government is watching these numbers closely, adding the wave appears to be ebbing.

“However, we will need to see the trend for about 10 days before reaching a conclusion,” he said. 

Health economist Rijo M John pointed out that at the national level, too, the most comforting factor is the low level of hospitalisation. 

National growth rate of active cases dipping?

“The national growth of active cases has been declining for the past couple of days. Testing may have declined a bit. But the TPR has not really gone up much despite a change in strategy towards more targeted testing,” pointed out health economist Rijo M John.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp